세계 RNAi 기술 시장 규모는 2023년 21억 달러에서 예측 기간 동안 14.8%의 CAGR로 2029년에는 48억 달러에 달할 것으로 예상됩니다.
치료제 부문은 2023년 16억 달러에서 연평균 16.2% 성장하여 2029년에는 39억 달러에 달할 것으로 예상됩니다. 툴 및 시약 부문은 2023년 5억 290만 달러에서 연평균 9.9% 성장하여 2029년에는 8억 8,280만 달러에 달할 것으로 예측됩니다.
세계 RNAi 기술 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 신흥 기술 및 기술 개발 동향, 시장 규모 추정 및 예측, 각 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
시장 전망
조사 범위
시장 개요
제2장 시장 개요
배경 : 유전 물질
RNA 간섭 개요
RNA 간섭 : 작용기서
개시 단계
이펙터 단계
작은 간섭 RNA(siRNA)
마이크로 RNA(miRNA)
소형 헤어핀 RNA(shRNA)
제3장 시장 역학
세계의 시장 역학
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
제4장 신기술과 개발
치료제
진단
비침습적 건강 모니터링을 위한 순환 miRNA 진단
농업
제5장 파이프라인 분석
제6장 특허 분석
제7장 시장 세분화 분석
세분화 내역
개요
시장 분석 : 기술별
치료제
RNAi 치료제 시장 : 지역별
RNAi 치료제 시장 : 치료 분야별
RNAi 치료제 시장 : 투여 방법별
진단
시약·툴
농업
지역적 내역
시장 분석 : 지역별
북미
유럽
신흥 시장
제8장 경쟁 정보
전략적 이니셔티브
경쟁 분석
제9장 RNAi 기술 시장의 지속가능성 : ESG 관점
ESG : 소개
RNAi 기술 업계의 지속가능성 : ESG 관점
환경에 대한 대처
사회공헌 활동
지배구조의 대처
사례 연구
BCC의 결론
제10장 부록
조사 방법
약어
정보 출처
기업 개요
ALNYLAM PHARMACEUTICALS INC.
ARROWHEAD PHARMACEUTICALS INC.
ARBUTUS BIOPHARMA CORP.
BAYER AG
MERCK KGAA
NOVARTIS AG
NOVO NORDISK A/S
OLIX PHARMACEUTICALS INC.
QIAGEN
REVVITY INC.
SILENCE THERAPEUTICS
SIRNAOMICS
SYLENTIS S.A.
SWITCH THERAPEUTICS
THERMO FISHER SCIENTIFIC INC.
ksm
영문 목차
영문목차
The global market for RNAi technology is estimated to increase from $2.1 billion in 2023 to reach $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 14.8% from 2024 through 2029.
The therapeutics market for RNAi technology is estimated to increase from $1.6 billion in 2023 to reach $3.9 billion by 2029, at a CAGR of 16.2% from 2024 through 2029.
The tools and reagents market for RNAi technology is estimated to increase from $502.9 million in 2023 to reach $882.8 million by 2029, at a CAGR of 9.9% from 2024 through 2029.
Report Scope
The scope of this study encompasses an investigation of the ribonucleic acid interference (RNAi) technology market. BCC Research analyzes RNAi technology based on technology type: tools and reagents, diagnostics, therapeutics, and agriculture. BCC Research determines the current market status in each segment, examines its impact on future needs, and presents growth forecasts over the next six years. The report provides a detailed analysis of the market's drivers, restraints, challenges, and opportunities. It includes company profiles of key players, with detailed information about their business segments, financials, product portfolios, and recent developments. The report also provides detailed information on emerging technologies and new developments in the market; examines the regulatory landscape; provides a patent and pipeline analysis; and discusses ESG developments, the investment outlook, and deals within the market.
Report Includes
26 data tables and 53 additional tables
An overview of the global market for RNAi technologies
Analysis of global market trends, featuring revenue data for 2021- 2023, estimated figures for 2024, forecasts for 2029, and projected CAGRs through 2029
Evaluation of the current market's size and revenue growth prospects, along with a market share analysis by type, therapeutic area, delivery method, and region
A look at innovations, technological advances, and recent product launches in the RNAi market
Analysis of the industry's regulatory framework and policies
A discussion of ESG challenges and ESG practices in the RNAi technologies industry
An analysis of the key companies' market shares, proprietary technologies, and strategic alliances
Company profiles of major players within the industry, including Alnylam Pharmaceuticals Inc., Novartis AG, Thermo Fisher Scientific Inc., and Revvity Inc.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Background: Genetic Material
RNA Interference Overview
RNA Interference: Mechanism of Action
Initiation Phase
Effector Phase
Small Interfering RNAs (siRNAs)
MicroRNAs (miRNAs)
Small Hairpin RNAs (shRNAs)
Chapter 3 Market Dynamics
Global Market Dynamics
Market Drivers
Increasing Prevalence of Chronic Disease
Increasing Approval of RNAi Products
Advancements in RNAi Delivery Systems
Increasing Strategic Initiatives
Convenient Dosing
Market Restraints
High Treatment Costs
Lack of Awareness
Market Opportunities
Expansion of Disease Targets
Combination Therapies
Untapped Genetic Targets
Chapter 4 Emerging Technologies and Developments
Therapeutics
Diagnostics
Circulating miRNA Diagnostics for Non-invasive Health Monitoring
Agriculture
Chapter 5 Pipeline Analysis
Chapter 6 Patent Analysis
Patent Analysis
Chapter 7 Market Segmentation Analysis
Segmentation Breakdown
Overview
Market Analysis by Technology
Therapeutics
RNAi Therapeutics Market, by Region
RNAi Therapeutics Market, by Therapeutic Area
RNAi Therapeutics Market, by Delivery Method
Diagnostics
Reagents and Tools
Agriculture
Geographic Breakdown
Market Analysis by Region
North America
Europe
Emerging Markets
Chapter 8 Competitive Intelligence
Strategic Initiatives
Competitive Analysis
Chapter 9 Sustainability in RNAi Technology Market: An ESG Perspective
Introduction to ESG
Sustainability in RNAi Technology Industry: An ESG Perspective
